Almirall e-MS Experts Summit Season 2020

Almirall, S.A. (ALM) announces the 8th edition of the MS Experts Summit continuous medical learning project, which will take place from June 10 to September 16, chaired by Prof. Christoph Kleinschnitz (Essen, Germany). The year edition will be conducted online for first time, with sessions streamed on seven days throughout June, July and September.

Under the title “People with MS: 360º evidence-based daily management,” several experts and researchers working in different areas of multiple sclerosis have prepared interesting lectures describing the latest advances across multiple aspects of managing patients who suffer from MS.

The inaugural session will address the issue of MS patients suffering from COVID-19, tackling their present needs as well as future vaccination requirements.

The Almirall e-MS Experts Summit will include two sessions on the use of cannabinoids in MS. Researchers will present the therapeutic benefits of phytocannabinoids from a scientific point of view, discussing the available evidence supporting the therapeutic effects of cannabinoids and describing the evidence-based approach for the use of medicinal cannabinoids. 

“We are delighted to once again provide our wholehearted support for this special edition of the MS Experts Summit, on this, the first time it is to be presented online. Although attendees will not participate live given the present circumstances, we expect the quality of the updated research presented by 18 eminent experts in MS to be consistent with our past events with interesting Q&A sessions following the presentations”, remarked Carlos Vila, Global Medical Lead, Almirall.

 Among other topics, the experts will address the similarities and differences in local guidance in various EU countries; recommendations from ECTRIMS and NICE in the UK concerning MS treatments, and  methods for the improved diagnosis and tracking of MS spasticity-related symptoms.

Parallel country-specific sessions will tackle MS-related issues in the EU.

New technologies and digitalization are naturally an important part of the program of this digital summit. Several experts will discuss how digital technology can help in providing holistic patient care. This session called How can digital technology help provide holistic patient care?, will also address emerging digital technologies which may help physicians manage their patients and current trends in digital innovation in MS.

The e-MS Experts Summit will offer attending EU MS healthcare professionals the opportunity to advance their knowledge of the impact of MS symptoms on patients’ daily activities as well as their quality of life. 

About Almirall 
Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying science to provide medical solutions to patients and future generations. Our efforts are focused on fighting skin health diseases and helping people feel better. We support healthcare professionals in their continuous improvements, providing our innovative solutions where they are needed.

The company was founded more than 75 years ago and has its headquarters in Barcelona. It is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key source of value creation for society thanks to its commitment to its principal shareholders and its decision to help others by understanding their challenges and using science to provide solutions for real life. Total Revenues in 2019 were more than 900 million euros. Almirall has c. 1,800 employees.

For more information visit https://www.almirall.com/